Discover 1,918 paid clinical trials in Georgia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Georgia presents extensive opportunities for healthy volunteers looking to participate in paid studies and individuals with specific health conditions alike. Research hubs in major cities like Atlanta, Augusta, and Savannah are actively recruiting participants, providing access to emerging therapies and top-tier medical care.
Filter
1
Filter results
Results: 1,918
Rise With Resilience
for
Athletic Injuries, Sport Injuries
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18 - 26
Code: NCT07217275
Recruiting
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
for
Rheumatoid Arthritis
Location: New Bedford MA, Trois-Rivieres, Baltimore MD,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07276581
Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Montreal, Farmington Hills MI, Atlanta GA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07541170
Phase 3, Recruiting
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
for
Obesity, Overweight, Chronic Weight Management,
Location: Methuen MA, Waterbury CT, The Bronx NY, Philadelphia PA,
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07654374
Phase 3, Recruiting
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
for
Attention Deficit Disorder With Hyperactivity (ADHD)
Location: East Providence RI, North Charleston SC, Maitland FL,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 65
Code: NCT07755410
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
for
Schizophrenia
Location: Marlton NJ, Gaithersburg MD, Hollywood FL,
Sponsor: Leal Therapeutics, Inc
Sex: All
Age: 18 - 55
Code: NCT07734493
Phase 1, Recruiting
A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
for
IgA Nephropathy, Lupus Nephritis (LN),
Location: Hollywood FL, Orangeburg SC, Lawrenceville GA
Sponsor: Akebia Therapeutics
Sex: All
Age: 16+
Code: NCT06419205
Phase 2, Recruiting
Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes
for
Diabetes Mellitus, Type 2
Location: Atlanta GA
Sponsor: Emory University
Sex: Female
Age: 65+
Code: NCT07428746
Phase 3, Recruiting
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
for
Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
for
Depressive Disorder, Treatment-Resistant
Location: Cedarhurst NY, New York NY, Marietta GA, Skokie IL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07716098
Phase 3, Recruiting
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
for
Multiple Myeloma, Smoldering Multiple Myeloma,
Location: Atlanta GA, Denver CO
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06768489
Phase 1, Recruiting
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Orange City FL, Clermont FL, Detroit MI, Atlanta GA,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 18+
Code: NCT04198766
Phase 1, Phase 2, Recruiting
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
for
Pulmonary Arterial Hypertension
Location: New York NY, Philadelphia PA, Falls Church VA,
Sponsor: Gossamer Bio USA, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06274801
Phase 3, Recruiting
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
for
Acute Myeloid Leukemia, Adult
Location: Baltimore MD, Chapel Hill NC, Pittsburgh PA,
Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland
Sex: All
Age: 18+
Code: NCT06652438
Phase 3, Recruiting
Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma
for
Oropharynx Cancer, Stage I
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT06254911
Phase 2, Recruiting
Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
for
Hypertriglyceridemia
Location: Quebec, Chicoutimi, Montreal, Little River SC,
Sponsor: Marea Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07028749
Phase 2, Recruiting
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
for
Carcinoma, Renal Cell
Location: Boston MA, New York NY, Morristown NJ, Ottawa,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07489495
Phase 3, Recruiting
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
for
HIV Infections
Location: Annandale VA, Fort Lauderdale FL, West Palm Beach FL,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07682961
Phase 3, Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
for
Myeloproliferative Neoplasms
Location: Boston MA, Chapel Hill NC, Toronto, Columbus OH,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07441694
Phase 1, Recruiting
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
for
Extrapulmonary Neuroendocrine Cancer (epNEC)
Location: Toronto, Knoxville TN, Atlanta GA, Nashville TN,